Bottom line
MSGAX vs VOO: the short answer
MSGAX (Meridian Small Cap Growth Fund) and VOO (Vanguard 500 Index Fund) are both mutual funds.
But VOO is far broader, holding 520 positions to 100 for MSGAX, so beyond the top names it adds exposure MSGAX doesn't have.
VOO is cheaper at 0.03% vs 1.51% — a difference of $148 a year per $10,000 invested.
Over five years, VOO returned +14.4% a year vs −1.1% for MSGAX.
MSGAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
MSGAX vs VOO side by side
| MSGAX | VOO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Meridian | Vanguard |
| Category | Small-Cap | S&P 500 Index |
| Expense ratio | 1.51% | 0.03% |
| Annual cost per $10k | $151 | $3 |
| 10-yr cost on $10k (prospectus) | $2,380 | $39 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −7.2% | +17.8% |
| 5-yr return (annualized) | −1.1% | +14.4% |
| 10-yr return (annualized) | +7.8% | +14.8% |
| Best quarter | — | +20.5% |
| Worst quarter | — | −19.6% |
| Net assets (fund) | $272.9M | $1.7T |
| Number of holdings | 100 | 520 |
| Portfolio turnover | 62% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MSGAX and VOO share none of their top holdings.
MSGAX top 10
- Stit Govt And Agency Inst — 6.34%
- Axogen Inc — 3.19%
- Federal Signal Corp — 2.33%
- Hinge Health Inc — 2.26%
- Goldman Sachs Trust — 2.17%
- Veracyte Inc — 2.11%
- Consensus Cloud Solutions Inc — 2.07%
- Apartment List Inc. Series D Preferred Stock — 2.02%
- Definium Therapeutics Inc — 1.99%
- Spx Technologies Inc — 1.98%
VOO top 10
- NVIDIA Corp — 7.51%
- Apple Inc — 6.59%
- Microsoft Corp — 4.30%
- Amazon.com Inc — 3.62%
- Alphabet Inc — 3.25%
- Broadcom Inc — 2.77%
- Alphabet Inc — 2.59%
- Micron Technology Inc — 2.02%
- Meta Platforms Inc — 1.92%
- Tesla Inc — 1.84%
FAQ
What is the difference between MSGAX and VOO?
Which is cheaper, MSGAX or VOO?
Should I own both MSGAX and VOO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.